Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8906)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2015 (publication date) through Aug 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Maletzki C, Gock M, Randow M, Klar E, Huehns M, Prall F, Linnebacher M. Establishment and characterization of cell lines from chromosomal instable colorectal cancer. World J Gastroenterol 2015; 21(1): 164-176 [PMID: 25574089 DOI: 10.3748/wjg.v21.i1.164] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i1/164.htm |
| Number | Citing Articles |
| 1 |
Florian Kuehn, Christina S. Mullins, Mathias Krohn, Christine Harnack, Robert Ramer, Oliver H. Krämer, Ernst Klar, Maja Huehns, Michael Linnebacher. Establishment and characterization of HROC69 – a Crohn´s related colonic carcinoma cell line and its matched patient-derived xenograft. Scientific Reports 2016; 6(1) doi: 10.1038/srep24671
|
| 2 |
Gabriele Picco, Consalvo Petti, Francesco Sassi, Katia Grillone, Giorgia Migliardi, Teresa Rossi, Claudio Isella, Federica Di Nicolantonio, Ivana Sarotto, Anna Sapino, Alberto Bardelli, Livio Trusolino, Andrea Bertotti, Enzo Medico. Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer. Journal of the National Cancer Institute 2017; 109(2): djw209 doi: 10.1093/jnci/djw209
|
| 3 |
Oksana Voloshanenko, Uwe Schwartz, Dominique Kranz, Benedikt Rauscher, Michael Linnebacher, Iris Augustin, Michael Boutros. β-catenin-independent regulation of Wnt target genes by RoR2 and ATF2/ATF4 in colon cancer cells. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-20641-5
|
| 4 |
Kristina Andrijauskaite, Jay Morris, Michael J. Wargovich. Epigenetics of Cancer Prevention. 2019; : 49 doi: 10.1016/B978-0-12-812494-9.00003-2
|
| 5 |
Sarah Rohde, Tobias Lindner, Stefan Polei, Jan Stenzel, Luise Borufka, Sophie Achilles, Eric Hartmann, Falko Lange, Claudia Maletzki, Michael Linnebacher, Änne Glass, Sarah Marie Schwarzenböck, Jens Kurth, Alexander Hohn, Brigitte Vollmar, Bernd Joachim Krause, Robert Jaster. Application of in vivo imaging techniques to monitor therapeutic efficiency of PLX4720 in an experimental model of microsatellite instable colorectal cancer. Oncotarget 2017; 8(41): 69756 doi: 10.18632/oncotarget.19263
|
| 6 |
Claudia Maletzki, Philine Scheinpflug, Anika Witt, Ernst Klar, Michael Linnebacher. Targeting Immune-Related Molecules in Cancer Therapy: A ComprehensiveIn VitroAnalysis on Patient-Derived Tumor Models. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/4938285
|
| 7 |
Nina Schoenwaelder, Mareike Krause, Thomas Freitag, Björn Schneider, Sarah Zonnur, Annette Zimpfer, Anne Sophie Becker, Inken Salewski, Daniel Fabian Strüder, Heiko Lemcke, Christina Grosse-Thie, Christian Junghanss, Claudia Maletzki. Preclinical Head and Neck Squamous Cell Carcinoma Models for Combined Targeted Therapy Approaches. Cancers 2022; 14(10): 2484 doi: 10.3390/cancers14102484
|
| 8 |
Stephanie Bock, Christina S. Mullins, Ernst Klar, Philippe Pérot, Claudia Maletzki, Michael Linnebacher. Murine Endogenous Retroviruses Are Detectable in Patient-Derived Xenografts but Not in Patient-Individual Cell Lines of Human Colorectal Cancer. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00789
|
| 9 |
Erika Durinikova, Kristi Buzo, Sabrina Arena. Preclinical models as patients’ avatars for precision medicine in colorectal cancer: past and future challenges. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-01981-z
|
| 10 |
Lili Lu, Randy Przybylla, Yuru Shang, Meng Dai, Mathias Krohn, Oliver Holger Krämer, Christina Susanne Mullins, Michael Linnebacher. Microsatellite Status and IκBα Expression Levels Predict Sensitivity to Pharmaceutical Curcumin in Colorectal Cancer Cells. Cancers 2022; 14(4): 1032 doi: 10.3390/cancers14041032
|
| 11 |
Michael Gock, Christina S Mullins, Carina Bergner, Friedrich Prall, Robert Ramer, Anja Göder, Oliver H Krämer, Falko Lange, Bernd J Krause, Ernst Klar, Michael Linnebacher. Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines. World Journal of Gastroenterology 2018; 24(43): 4880-4892 doi: 10.3748/wjg.v24.i43.4880
|
| 12 |
Claudia Maletzki, Maja Huehns, Patrick Knapp, Nancy Waukosin, Ernst Klar, Friedrich Prall, Michael Linnebacher, Hiromu Suzuki. Functional Characterization and Drug Response of Freshly Established Patient-Derived Tumor Models with CpG Island Methylator Phenotype. PLOS ONE 2015; 10(11): e0143194 doi: 10.1371/journal.pone.0143194
|
| 13 |
Christina S. Mullins, Maja Hühns, Mathias Krohn, Sven Peters, Valérie Cheynet, Guy Oriol, Michèle Guillotte, Sandrine Ducrot, François Mallet, Michael Linnebacher, Robert Belshaw. Generation, Characterization and Application of Antibodies Directed against HERV-H Gag Protein in Colorectal Samples. PLOS ONE 2016; 11(4): e0153349 doi: 10.1371/journal.pone.0153349
|
| 14 |
Falko Lange, Katrin Porath, Tina Sellmann, Anne Einsle, Robert Jaster, Michael Linnebacher, Rüdiger Köhling, Timo Kirschstein. Direct-Current Electrical Field Stimulation of Patient-Derived Colorectal Cancer Cells. Biology 2023; 12(7): 1032 doi: 10.3390/biology12071032
|
| 15 |
Stephanie Matschos, Florian Bürtin, Said Kdimati, Mandy Radefeldt, Susann Krake, Friedrich Prall, Nadja Engel, Mathias Krohn, Bianca Micheel, Michael Kreutzer, Christina Susanne Mullins, Michael Linnebacher. The HROC-Xenobank—A High Quality Assured PDX Biobank of >100 Individual Colorectal Cancer Models. Cancers 2021; 13(23): 5882 doi: 10.3390/cancers13235882
|
| 16 |
Dominik Wilms, Jörg Andrä. Comparison of patient-derived high and low phosphatidylserine-exposing colorectal carcinoma cells in their interaction with anti-cancer peptides. Journal of Peptide Science 2017; 23(1): 56 doi: 10.1002/psc.2963
|
| 17 |
Michael Gock, Christina S Mullins, Christine Harnack, Friedrich Prall, Robert Ramer, Anja Göder, Oliver H Krämer, Ernst Klar, Michael Linnebacher. Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line. World Journal of Gastroenterology 2018; 24(33): 3749-3759 doi: 10.3748/wjg.v24.i33.3749
|
| 18 |
Michael Gock, Marcel Kordt, Stephanie Matschos, Christina S. Mullins, Michael Linnebacher. Patient-individual cancer cell lines and tissue analysis delivers no evidence of sequences from DNA viruses in colorectal cancer cells. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01404-x
|
| 19 |
Randy Przybylla, Christina Susanne Mullins, Mathias Krohn, Stefan Oswald, Michael Linnebacher. Establishment and Characterization of Novel Human Intestinal In Vitro Models for Absorption and First-Pass Metabolism Studies. International Journal of Molecular Sciences 2022; 23(17): 9861 doi: 10.3390/ijms23179861
|
| 20 |
Annika Kayser, Annabell Wolff, Peggy Berlin, Lara Duehring, Larissa Henze, Ralf Mundkowski, Wendy Bergmann, Brigitte Müller-Hilke, Charlotte Wagner, Maja Huehns, Sonja Oehmcke-Hecht, Claudia Maletzki. Selective but not pan-CDK inhibition abrogates 5-FU-driven tissue factor upregulation in colon cancer. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-61076-5
|
| 21 |
Sonja Oehmcke-Hecht, Vanessa Mandl, Lukas Tim Naatz, Lara Dühring, Juliane Köhler, Bernd Kreikemeyer, Claudia Maletzki. Streptococcus gallolyticus abrogates anti-carcinogenic properties of tannic acid on low-passage colorectal carcinomas. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-61458-5
|
| 22 |
Armin Wiegering, Niels Matthes, Bettina Mühling, Monika Koospal, Anne Quenzer, Stephanie Peter, Christoph-Thomas Germer, Michael Linnebacher, Christoph Otto. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin. Neoplasia 2017; 19(4): 301 doi: 10.1016/j.neo.2017.01.007
|